Markets ABT

Abbott : FreeStyle Libre 3 Integrated With Automated Insulin Delivery System Mylife Loop In Germany

December 21, 2022 — 09:56 am EST

Written by RTTNews.com for RTTNews

(RTTNews) - Abbott (ABT) announced that its FreeStyle Libre 3 sensor is now compatible with the mylife Loop solution from partners, Ypsomed and CamDiab, creating a smart, automated process to deliver insulin based on real-time glucose data.

The company noted that the automated insulin delivery system (AID) solution is now available in Germany and will be available in additional European countries beginning in 2023. But the AID solution is currently not available in the United States.

Integrating CamDiab's CamAPS FX mobile app and Ypsomed's mylifeTM YpsoPump with accurate, real-time data from Abbott's FreeStyle Libre 3 sensor, the connected solution continuously monitors a person's glucose levels, and automatically adjusts and delivers the right amount of insulin at the right time, removing the guesswork of insulin dosing and helping people with diabetes reach better treatment targets.

In addition to partnering with Ypsomed and CamDiab, Abbott said it is working to make the FreeStyle Libre platform interoperable with other leading insulin delivery systems.

RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source

Tags

Markets
Stocks Mentioned
ABT

Latest Articles
Data is currently not available